Evolution of neoplastic development in the liver of transgenic mice co- expressing c-myc and transforming growth factor-α

American Journal of Pathology

Volumn 149, Issue 2, 1996, Pages 407-428

  Santoni Rugiu, Eric ^a   Nagy, Peter ^a   Jensen, Michael R ^a   Factor, Valentina M ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; INCIDENCE; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; PHENOTYPE; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0030036244     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Amati B, Land H: Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation, and death. Curr Opin Genet Dev 1994, 4:102-108
2. DePinho RA, Schreiberg-Agus N, Alt FW: MYC family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 1991, 57:1-46
3. Zhang XK, Huang DP, Chin DK, Chin JF: The expression of oncogenes in human developing liver and hepatomas. Biochem Biophys Res Commun 1987, 142: 932-938
4. Tabor E: Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994, 42:357-365
5. Moroy T, Marchio A, Etiemble J, Trepo C, Tiollais P, Buendia M: Rearrangement and enhanced expression of c-myc gene in hepatocellular carcinoma of hepatitis virus-infected woodchucks. Nature 1986, 324:276-279
6. Nagy P, Evarts RP, Marsden E, Roach J, Thorgeirsson SS: Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats. Cancer Res 1988, 48:5522-5527
7. Hunter T: Cooperation between oncogenes. Cell 1991, 64:249-270
8. Murakami H, Sanderson N, Nagy P, Marino P, Merlino GT, Thorgeirsson SS: Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and TGF-α in hepatic oncogenesis. Cancer Res 1993, 53:1719-1723
9. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC: Transforming growth factor-α dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993, 13:320-330
10. Tönjes RR, Löhler J, O'Sullivan JF, Kay GF, Schmidt GH, Dalemans W, Pavirani A, Paul D: Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice. Oncogene 1995, 10:765-768
11. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL: Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989, 4:715-724
12. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC: Overexpression of TGF-α in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990, 61:1121-1135
13. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT: TGFα Overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990, 61: 1137-1146
14. Lee GH, Merlino G, Fausto N: Development of liver tumors in transforming growth factor-α transgenic mice. Cancer Res 1992, 52:5162-5170
15. Amundadottir LT, Jhonson MD, Merlino G, Smith GH, Dickson RB: Synergistic interaction of transforming growth factor-α and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ 1995, 6:737-748
16. Stern DF, Roberts AB, Roche NS, Sporn MB, Weinberg RA: Differential responsivenesss of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor. Mol Cell Biol 1986, 6:870-877
17. Strom SC, Faust JB, Capelluti E, Harris RB, Lalwani ND: Characterization of liver epithelial cells transfected with c-myc and/or ras oncogenes. Dig Dis Sci 1991, 36: 642-652
18. Lee LW, Raymond VW, Tsao M-S, Lee DC, Earp HS, Grisham JW: Clonal segregation of tumorigenicity with overexpression of c-myc and transforming growth factor-α genes in chemically transformed rat liver epithelial cells. Cancer Res 1991, 51:5238-5244
19. Frith CH, Ward JM, Turosov VS: Tumours of the liver. Pathology of Tumours in Laboratory Animals, vol 2. Edited by V Turosov, U Mohr. Lyon, France, IARC Scientific Publications, 1994, pp 223-270
20. Flanders KC, Thompson NL, Cissel DS, Obberghen-Schilling EV, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB: Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J Cell Biol 1989, 108:653-660
21. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, Jirtle R, Flanders K, Tsang ML-S: Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am J Pathol 1995, 147:1228-1237
22. Gentry LE, Twardzik DR, Lim GJ, Ranchalis JE, Lee DC: Expression and characterization of transforming growth factor-α precursor protein in transfected mammalian cells. Mol Cell Biol 1987, 7:1585-1591
23. Engelhardt N, Factor V, Yasova A, Poltoranina V, Baranov W, Lasareva M: Common antigens of mouse oval and biliary epithelial cells: expression of newly formed hepatocytes. Differentiation 1990, 45:29-37
24. Takagi H, Sharp R, Takayama H, Anver MR, Ward JM, Merlino G: Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor-α transgenic mice. Cancer Res 1993, 53:4329-4336
25. Webber EM, Wu JC, Wang L, Merlino G, Fausto N: Overexpression of transforming growth factor-α causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994, 145:398-408
26. Fausto N, Webber EM: Liver regeneration. The Liver: Biology and Pathobiology, ed 3. Edited by IM Arias, JL Boyer, N Fausto, WB Jakoby, DA Schachter, DA Shafritz. New York, Raven Press, 1994, pp 1059-1084
27. Hsia C-C, Axiotis CA, DiBisceglie AM, Tabor E: Transforming growth factor-α in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver. Cancer 1992, 70:1049-1056
28. Collier JD, Guo K, Gullick WJ, Bassendine MF, Burt AD: Expression of transforming growth factor-α in human hepatocellular carcinoma. Liver 1993, 13:151-155
29. Takagi H, Sharp R, Hammermeister C, Goodrow T, Bradley MO, Fausto N, Merlino G: Molecular and genetic analysis of liver oncogenesis in transforming growth factor-α transgenic mice. Cancer Res 1992, 52:5171-5177
30. Oberhammer F, Pavelka M, Sharma S, Tiefenbacher R, Purchio TA, Bursch W, Schulte-Hermann R: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β1. Proc Natl Acad Sci USA 1992, 89:5408-5412
31. Bursch W, Oberhammer F, Jirtle RL, Askari M, Sedivy R, Grasl-Kraupp B, Purchio AF, Schulte-Hermann R: Transforming growth factor-β1 as a signal for induction of cell death by apoptosis. Br J Cancer 1993, 67:531-536
32. Oberhammer F, Bursch W, Tiefenbacher R, Fröschl G, Pavelka M, Purchio T, Schulte-Hermann R: Apoptosis is induced by transforming growth factor-β1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology 1993, 18:1238-1246
33. Lyons RM, Gentry LE, Purchio AF, Moses HE: Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J Cell Biol 1990, 110: 1361-1367
34. Odekon LE, Blasi F, Rifkin DB: Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J Cell Physiol 1994, 158:398-407
35. Wu JC, Merlino G, Cveklova K, Mosinger B Jr, Fausto N: Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte line that overexpress transforming growth factor-α. Cancer Res 1994, 54:5964-5973
36. Collins Presnell S, Thompson MT, Strom SC: Investigation of the cooperative effects of transforming growth factor-α and c-myc overexpression in rat liver epithelial cells. Mol Carcinogen 1995, 13:233-244
37. Anthony PP, Vogel CL, Barker LF: Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973, 26:217-223
38. Cohen C, Berson SD, Geddes EW: Liver cell dysplasia: association with hepatocellular carcinoma, cirrhosis, and hepatitis B antigen carrier status. Cancer 1979, 44:1671-1676
39. Cohen C, Berson SD: Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients. Cancer 1986, 57:1535-1538
40. Roncalli M, Borzio M, De Biagi G, Ferrari AR, Macchi R, Tombesi MV, Servida E: Liver cell dysplasia in cirrhosis: a serologic and immunohistochemical study. Cancer 1986, 57:1515-1521
41. Lefkowitch JH, Apfelbaum TF: Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis. Arch Pathol Lab Med 1987, 111:170-173
42. Wada K, Kondo F, Kondo Y: Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study. Hepatology 1988, 8:1684-1688
43. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, Takahashi T: Morphologic studies of the liver cell dysplasia. Cancer 1983, 51:2197-2205
44. Roncalli M, Borzio M, Tombesi MV, Ferrari AR, Servida E: A morphometric study of liver cell dysplasia. Hum Pathol 1988, 19:471-474
45. International Working Party: Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993
46. Toshkov I, Chisari FV, Bannasch P: Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology 1994, 20:1162-1172
47. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K: High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994, 19:810-819
48. Sepulveda AR, Finegold MJ, Smith B, Slagle BL, DeMayo JL, Shen R-F, Woo SLC, Butel JS: Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue specific expression of SV-40 large T antigen controlled by regulatory elements of a human α-1 antitrypsin gene. Cancer Res 1989, 49:6108-6117
49. Schirmacher P, Held WA, Yang D, Biempica L, Rogler CE: Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV 40 large Tag transgenic mice. Am J Pathol 1991, 139:231-241
50. Hunter T, Pines J: Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 1994, 79:573-582
51. Sargent LM, Sanderson ND, Thorgeirsson SS: Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-Myc and TGF-α transgenes. Cancer Res 1996, 56:2137-2142
52. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995, 7:812-821
53. WAF1/CIP1 induces growth arrest, giant cell formation, and apoptosis in human breast carcinoma cell lines. Oncogene 1995, 11:1899-1905
54. 2-phase of the cell cycle by 9-nitrocamptothecin. Lab Invest 1995, 73: 118-127
55. McWhir J, Selfridge J, Harrison DJ, Squires S, Melton DW: Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nature Genet 1993, 5:217-224
56. Nagy P, Evarts RP, McMahon JB, Thorgeirsson SS: Role of TGFβ in normal differentiation and oncogenesis in rat liver. Mol Carcinogen 1989, 2:345-354
57. Nakatsukasa H, Evarts RP, Hsia C-H, Marsden E, Thorgeirsson SS: Expression of transforming growth factor-β1 during chemical hepatocarcinogenesis in the rat. Lab Invest 1991, 65:511-517
58. Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S: Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 1991, 51:4080-4083
59. Bedossa P, Peltier E, Terris B, Franco D, Poynard T: Transforming growth factor-β1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 1995, 21:760-766
60. Ohno K, Amman P, Fasciati R, Maier P: Transforming growth factor β1 preferentially induces apoptotic cell death in rat hepatocytes cultured under pericentral-equivalent conditions. Toxicol Appl Pharmacol 1995, 132:227-236
61. Fausto N: Editorial: multifunctional roles for transforming growth factor-β1. Lab Invest 1991, 65:495-499
62. Moses HE, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990, 63:245-247
63. Nakatsukasa H, Nagy P, Evarts RP, Hsia C, Marsden E, Thorgeirsson SS: Cellular distribution of TGF-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride induced rat liver fibrosis. J Clin Invest 1990, 85:1833-1843
64. Braun L, Mead JE, Panzica M, Mikuma R, Bell GI, Fausto N: Transforming growth factor-β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988, 85:1539-1543
65. Kristensen P, Eriksen J, Danø K: Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 1991, 39:341-349
66. Huber K, Kirchheimer JC, Ermler D, Bell C, Binder BR: Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with α-fetoprotein. Cancer Res 1992, 52: 1717-1720
67. Mars WM, Zarnegar R, Michalopoulos GK: Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993, 143:949-958
68. Testa JE, Quigley JP: The role of urokinase-type plasminogen activator in aggressive tumor cell behavior Cancer Metastasis Rev 1990, 9:353-367
69. Vassalli J-D, Pepper MS: Membrane proteases in focus. Nature 1994, 370:14-15
70. Gavrilovic J, Moens G, Thiery JP, Jouanneau J: Expression of transfected transforming growth factor-α induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. Cell Regul 1990, 1:1003-1014
71. Dalai BI, Keown PA, Greenberg AH: Immunocytochemical localization of selected transforming growth factor-β1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol 1993, 143:381-389
72. Busso N, Nicodeme E, Chesne C, Guillouzo A, Belin D, Hyafil F: Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology 1994, 20:186-190
73. Koen H, Pugh TD, Goldfarb S: Hepatocarcinogenesis in mice. Combined morphologic-stereologic studies. Am J Pathol 1983, 112:89-100
74. Koen H, Pugh TD, Nychka D, Goldfarb S: Presence of α-fetoprotein-positive cells in hepatocellular foci and microcarcinomas induced by single injections of dieth-ylnitrosamine in infant mice. Cancer Res 1983, 43:702-708
75. Paradinas FJ, Bul TB, Westaby D, Murray-Lion IM: Hyperplasia and prolapse of hepatocytes into hepatic veins during long term methyltestoterone therapy: possible relationships of these changes to the development of peliosis hepatis and liver tumors. Histopathology 1977, 1:225-246
76. Thorgeirsson SS: Stem cells and hepatocarcinogenesis. Liver Regeneration and Carcinogenesis: Cellular and Molecular Mechanisms. Edited by RL Jirtle. New York, Academic Press, 1995, pp 99-112
77. Bennoun M, Rissel M, Engelhardt N, Guillouzo A, Briand P, Weber-Benarous A: Oval cell proliferation in early stages of hepatocarcinogenesis in Simian virus 40 large T transgenic mice. Am J Pathol 1993, 143: 1326-1336
78. Factor VM, Radaeva SA, Thorgeirsson SS: Origin and fate of oval cells in Dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol 1994, 145:409-422
79. Chuang LY, Tsai JH, Yeh YC, Chang CC, Yeh HW, Guh JY, Tsai JF: Epidermal growth factor-related transforming growth factors in the urine of patients with hepato-cellular carcinoma. Hepatology 1991, 13:1112-1116
80. Tabor E, Farshid M, DiBisceglie AM, Hsia CC: Increased expression of transforming growth factor-α after transfection of a human hepatoblastoma cell line with hepatitis B virus. J Med Virol 1992, 37:271-273
81. Santoni-Rugiu E, Preisegger K-H, Kiss A, Audolfsson T, and Thorgeirsson SS: Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 1996 (in press)